US Patent Issued to The Johns Hopkins University, UNIVERSITY OF MARYLAND, BALTIMORE, THE KENNEDY KRIEGER INSTITUTE on Sept. 1 for "Humanized antibodies directed against KCNK9" (Maryland Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,075, issued on Sept. 1, was assigned to The Johns Hopkins University (Baltimore), UNIVERSITY OF MARYLAND, BALTIMORE (Baltimore) and THE KENNEDY KRIEGER INSTITUTE INC. (Baltimore).

"Humanized antibodies directed against KCNK9" was invented by John J. Laterra (Baltimore) and Amy M. Fulton (Baltimore).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are humanized monoclonal antibodies that bind to potassium two pore domain channel subfamily K member 9 (KCNK9). The humanized monoclonal antibodies comprise (a) a heavy chain variable region comprising an amino acid sequence of SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, or SEQ ...